BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8801747)

  • 21. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
    Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
    Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
    Seaberg RM; Eski S; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgical treatment of metastases from thyroid cancer in the axial skeleton. A retrospective study of 18 cases].
    Court C; Noun Z; Gagey O; Nordin JY
    Acta Orthop Belg; 2000 Oct; 66(4):345-52. PubMed ID: 11103485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of thyroid tumor aggressiveness.
    Clark OH
    West J Med; 1996 Sep; 165(3):131-8. PubMed ID: 8909165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up.
    van der Wal JE; Becking AG; Snow GB; van der Waal I
    Head Neck; 2002 Aug; 24(8):779-83. PubMed ID: 12203804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms].
    Guo GF; Yang AK; Xie RH; Chen ZH; Wu QL; Ou SM; Liu WW; Xia LP; Chen MY; Zhang JX; Wu JH
    Ai Zheng; 2004 Nov; 23(11 Suppl):1546-50. PubMed ID: 15566677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.
    Shoup M; Stojadinovic A; Nissan A; Ghossein RA; Freedman S; Brennan MF; Shah JP; Shaha AR
    J Am Coll Surg; 2003 Aug; 197(2):191-7. PubMed ID: 12892796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Management of metastasis. Medullary cancers excluded].
    Chigot JP
    Ann Endocrinol (Paris); 1997; 58(4):335-7. PubMed ID: 9436484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the frequency of radioiodine uptake by distant metastases from differentiated cancers of the thyroid gland].
    Löhr H; Schneider C; Meradji M
    Strahlentherapie Sonderb; 1965; 61():411-6. PubMed ID: 5830910
    [No Abstract]   [Full Text] [Related]  

  • 30. Papillary thyroid carcinoma: factors influencing recurrence and survival.
    Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
    Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of dose to thyroid carcinoma metastases from radio-iodine therapy.
    Scott JS; Halnan KE
    Br J Radiol; 1970 Apr; 43(508):256-62. PubMed ID: 5442489
    [No Abstract]   [Full Text] [Related]  

  • 32. [Distant metastasis of differentiated thyroid cancers. Diagnosis by 131 iodine (I 131) and treatment].
    Leger AF
    Ann Endocrinol (Paris); 1995; 56(3):205-8. PubMed ID: 7677405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distant metastases of thyroid cancer--treatment and survival.
    Nĕmec J; Zamrazil V; Fexa J; Holub V; Pohunkova D; Vaña S; Neradilova M
    Radiobiol Radiother (Berl); 1987; 28(5):705-7. PubMed ID: 3441633
    [No Abstract]   [Full Text] [Related]  

  • 34. Pulmonary metastases from thyroid carcinoma detectable only by 131 I scan. Treatment and response.
    Turner JE; Weir GJ
    J Nucl Med; 1972 Nov; 13(11):852-5. PubMed ID: 5080021
    [No Abstract]   [Full Text] [Related]  

  • 35. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
    Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Principles of radionuclide methods of diagnosing and treating primary thyroid cancer and its metastases].
    Purizhanskiĭ II; Lushina LI; Lyzhina VD; Lisenkov PI
    Med Radiol (Mosk); 1982 Oct; 27(10):61-6. PubMed ID: 7176859
    [No Abstract]   [Full Text] [Related]  

  • 37. Polyphosphate bone scans, 32phosphorus, and adenocarcinoma of the thyroid.
    Klinger L
    J Nucl Med; 1974 Nov; 15(11):1037-8. PubMed ID: 4138748
    [No Abstract]   [Full Text] [Related]  

  • 38. The treatment of painful osseous metastases with phosphorus-32-labeled phosphates.
    Silberstein EB
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):10-21. PubMed ID: 7684860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Functional state of the hematopoietic system during treatment of distant metastases of thyroid neoplasms with radioactive iodine].
    Sokolova II; Reznichenko FM; Kiseleva ES; Brin ML
    Med Radiol (Mosk); 1975 Nov; 20(11):80-2. PubMed ID: 1226074
    [No Abstract]   [Full Text] [Related]  

  • 40. [Metabolic curietherapy with P-32 in bone metastases in breast cancer].
    Navarro-Izquierdo AL; Baringo T; Domínguez J; Duque JJ; Martínez Comín L; Solsona F
    Rev Esp Oncol; 1980; 27(1):101-6. PubMed ID: 6163183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.